Dear friends,
I thought you might find of interest the new book that has just been published entitled: “Anti-aging Drugs: From Basic Research to Clinical Practice” by the Royal Society of Chemistry, including the chapters on “Anti-Aging Drugs: Where are We and Where are We Going?” by Alexander Vaiserman (the book editor), “Human life extension: opportunities, challenges, and implications for public health policy” by Ilia Stambler, and others.
It is available at:
http://pubs.rsc.org/en/content/ebook/978-1-78262-435-6#!divbookcontent
I also use this opportunity to draw your attention to an additional new article on life-extension and public health policy: Ilia Stambler. Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy. Aging and Disease, 8 (5), 2017. doi: 10.14336/AD.2017.0130 (free and open access)
http://www.aginganddisease.org/article/0000/2152-5250/147600
The article and the chapter argue for the urgent need to develop evidence-based diagnostic and therapy efficacy and safety criteria for degenerative aging processes. Hopefully it will increase interest and discussion of such criteria.
Thanks for sharing and spreading the word about it in your circles. Will be grateful for any additional suggestions for how this critical issue of support for diagnostic and therapeutic research of aging can be further promoted and discussed.
Thankfully yours,
Ilia Stambler, PhD
Chair. Israeli Longevity Alliance
CSO. Vetek (Seniority) Association
http://www.longevityisrael.org/
http://www.longevityforall.org/
Ilia Stambler, PhD
Outreach Coordinator. International Society on Aging and Disease - ISOAD http://isoad.org
Chair. Israeli Longevity Alliance / International Longevity Alliance (Israel) - ILA http://www.longevityisrael.org/
Coordinator. Longevity for All http://www.longevityforall.org
Author. Longevity History. A History of Life-Extensionism in the Twentieth Century http://longevityhistory.com
Email: ilia.s...@gmail.com
Tel: 972-3-961-4296 / 0522-283-578
Rishon Lezion. Israel